Lonza - PBMCs

EDITORIAL SECTION

KNOWLEDGE BANK

  • Articles

    FDA Drug Approval Pathways: Strategies for U.S. Pharmaceutical Companies

    Getting a new medicine from the lab bench to a patients medicine cabinet is one of the longest costliest and most heavily scrutinized journeys in American business For every drug that reaches pharmacy shelves thousands of molecules never make it out of early testing The difference between the ones that succeed and the ones that stall often isnt the science alone its the regulatory strategy behind...

TOP ARTICLES

press releasesRead more...

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Jazz Pharmaceuticals plc Nasdaq JAZZ Jazz or the Company today announced the successful completion of its acquisition of privatelyheld Actio Biosciences Inc Actio for million upfront Actio

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing

Asahi Kasei Bioprocess a subsidiary of diversified global company Asahi Kasei will unveil the VANTIJ SUVFC Benchtop at Bioprocess International East BPI EAST This new VANTIJ SUVFC is a smallformat system

Piramal Critical Care Announces U.S. Launch of Erythromycin Lactobionate for Injection, USP

Piramal Critical Care PCC a division of Piramal Pharma Limited PPL NSE PPLPHARMA I BSE today announced the US launch of Erythromycin Lactobionate for Injection USP mg SingleDose Vial This product further expands PCCs growing portfolio of generic injectables

Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development

Psyence Biomedical Ltd Nasdaq PBM Psyence BioMed or the Company a biopharmaceutical company developing naturederived neuroplastogen therapeutics today announced the formation

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 02

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

LATEST NEWSRead more...

VaxThera and Codagenix partner to advance next-generation yellow fever vaccine

VaxThera SAS a Colombian biotechnology company developing and manufacturing vaccines and biological products has entered into an agreement with Codagenix Inc to exclusively license

BostonGene expands collaboration with Dana-Farber to advance breast cancer research

BostonGene has expanded its scientific collaboration with DanaFarber Cancer Institute to study the biological mechanisms involved in BRCA and BRCAassociated breast cancers

Curium Receives FDA Approval for BEXLUTRY Radioligand Therapy for GEP-NETs

Curium has received approval from the US Food and Drug Administration FDA for BEXLUTRY lutetium Lu dotatate injection to treat adults with somatostatin receptorpositive gastroenteropancreatic neuroendocrine tumours GEPNETs

Aptar Pharma and Massachusetts General Hospital Partner on Nose-to-Brain Drug Delivery Research

Aptar Pharma and Massachusetts General Hospital MGH have entered into a research collaboration to advance nosetobrain NB drug delivery for neurological and central nervous system CNS diseases

ABEC Opens New Manufacturing Facility in North Carolina

ABEC has opened a new manufacturing facility in Wilson North Carolina expanding its global production network and strengthening support for the growing biopharmaceutical industry

Biora Therapeutics to Initiate First Human Study of BioJet Oral Biologic Delivery Capsule

Biora Therapeutics plans to begin its first human clinical study of BioJet an ingestible capsule designed to deliver medicines directly into the small intestine using liquid jet technology